Select
1 H NMR STUDY ON THE STEREOCHEMISTRY OF 1,3-OXAZINO[3,2-D] [1,5] BENZODIAZEPINE-1-ONES
XU Hao, XU Jia-xi, LIU Xue-hui, JIN Sheng, CUI Yu-xin
Chinese Journal of Magnetic Resonance, 2000, 17(5): 362-367.
A series of 1,3-oxazino[3,2-d] [1,5] benzodiazepine-1-one derivatives' stereochemistry was studied by 1 H NMR. During the 1 H NMR experiments, we found out their unique stereochemistry of seven-membered rings. All the discernible hydrogen's chemical shifts were assigned. Their distorted boat conformations were discovered by the related coupling constants and gNOESY results, which were compared with x-ray diffraction result and the conformation of analogous benzothioazepines.
Select
THE NMR STUDY ON A NEW GLUCOSIDE OF GLYCOSIDE MARTYNOSIDE
SU Fu, WANG Xiao-ming, WANG Hua-yuan
Chinese Journal of Magnetic Resonance, 2000, 17(5): 369-374.
A novel phenylpropanoid glycoside, named Martynoside, was isolated from cassiope selaginoids Hook. f.et T.Thoms. The structure of this glycoside was identified by spectral methods, including IR.MS. 1 H NMR, 13 C NMR, DEPT, ORD, NOEDS and two dimensional Long-range coupling techniques.
Select
COMPLETE ASSIGNMENT OF NMR CHEMICAL SHIFTS OF CHLOROMALOSIDE A AND B
TENG Rong-wei, YANG Qing-xiong, WANG De-zu, YANG Chong-ren
Chinese Journal of Magnetic Resonance, 2000, 17(5): 375-381.
By means of 2D NMR techniques, such as HMQC TOCSY,TOCSY,ROESY,HMQC,HMBC and COSY, the structures of chloromaloside A and B, two new C-27 steroidal saponins from Chlorophytum malayense were confirmed. Their complete assignment of 1 H and 13 C NMR chemical shifts were also obtained.
Select
STUDY ON THE STRUCTURE OF INHIBITORS OF THE MDM2 ONCOGENE
An Dong-ge, TU Guang-zhong, YIN Da-li, HE Wen-yi, MA Li-bin, KONG Man
Chinese Journal of Magnetic Resonance, 2000, 17(5): 383-388.
The MDM2 oncoprotein is a cellular inhibitor of the P53 tumor suppressor in that it can bind the transactivation domain of P53 and downregulate its ability to activate transcription. In certain cancers, MDM2 amplification is a common event and contributes to the inactivation of P53. The crystal structure of the MDM2 bound to P53 has been analysised through x-ray crystallography. The crystal structure provides a framework for the discovery of compounds that may prevent the activation of the P53 tumor suppressor by the MDM2 oncogene in cancer. Inhibitors of the MDM2 oncogene have been synthesized on the base of this theory. All assignments of inhibitors were obtained from 1 H、13 C、1 H-1 H COSY、HMQC and HMBC spectra. With regarded to count space distance of two benzene rings, three-bond coupling constants were utilized to determine the structure of inhibitors. Sterostructures and relative configurations were discussed, and dominant energy was computed by using Sybyl software.
Select
STUDY ON SOLUTION CHEMISTRY OF SOME V/S, V/Fe/S AND Mn/O CLUSTER COMPOUNDS BY NMR SPECTROSCOPY
CHEN Chang-neng, ZHU Hong-ping, ZHANG Yan-shi, LIU Qiu-tian, WU Da-xu
Chinese Journal of Magnetic Resonance, 2000, 17(5): 389-394.
This paper reports some interesting prollemsion solution chemistry of V/S,V/Fe/S and Mn/O cluster compounds by their NMR studies. The 1 H NMR spectrum of[V4 S4 (C4 H8 NCS2 )6 ]- shows three broad resonances at 4.77, 5.17 and 7.57ppm which were assigned to the α -H of C4 H8 NCS2 ligands in terminal and bridged ligations. The signals of free C4 H8 NCS2 are also observed, which occur from an exchange between the R2 NCS2 ligand and the solvent molecules. The 1 H NMR spectra of a series of[VFe3 S4 (R2 NCS2 )4 ]- were determined in DMSO-d6 , exhibiting two sets of signals assigned to the α -H of the R2 NCS2 ligands linking to V and Fe sites, respectively. A broad peak centered at 19.6ppm for complex 2 or at 33ppm for 3 was found to grow up with time going on, indicating the formation of Fe4 S4 (R2 NCS2 )4 (R2 =OC4 H8 ,Et2 ). This assignment was identified by a dynamic tracing 1 H NMR experiment in which Fe4 S4 (R2 NCS2 )4 was synthesized and its 1 H NMR signals were monitored. A possible metal exchange accompanying the formation of Fe4 S4 (R2 NCS2 )4 in DMSO solution was suggested. The 1 H NMR spectrum of mononuclear Mn bpy complex 4 containing H2 O and NO3 ligands was determined, indicating the exchangeability of these monodentate ligands, which makes 4 become an inclusion compound including two mononuclear Mn molecules.
Select
THE EFFECT OF BUFALIN ON THE STRUCTURE OF PHOSPHOLIPID LIPOSOME AS STUDIED BY 31 P NMR SPECTROSCOPY
LUO Hui-jun, PAN Tie-ying, SHI Xin-mei, LI ANG-Wei, HOU Hui-min
Chinese Journal of Magnetic Resonance, 2000, 17(5): 395-399.
The egg yolk phosphatidylcholine(PC) liposomes loaded with bufalin(BF) were prepared so as to improve BF's therapeutic effect. The effects of BF on PC model membrane have been examined using the 31 P NMR spectroscopy. The results show that the incorporation of BF into PC liposome can stabilize the lipid bilayer structure of PC, with the basal linewidth of the 31 P spectrum increasing with increasing the content of BF in liposome. This may be related to the formation of hydrogen bonding between BF and polar headgroup of PC, or insertion of BF into PC by hydrophobic interaction. On the other hand, it was found for the first time that after exposure to ultrasonic waves, pure PC shows an additional narrow peak at the isotropic chemical shift (i.e., about 0.23ppm) in its 31 P spectrum which corresponds to the mobile lipidic particles, e.g., micelles or small resicles, and furthermore, the addition of BF can significantly trigger such a transition from the phospholipid bilaryer to the micellar phase. This could be explained by the insertion of BF into the micellar phase or the formation of mobile BF-PC complexes. These studies demonstrate that the presence of BF has two-sided effect on the membrane structure of PC, depending on the preparation conditions of the liposome. Therefore, on preparing the BF-loaded liposome, partial attention should be paid to the potential influence of the preparation conditions on the structure and then physiochemical properties of the liposome, in addition to the effects of the medicine itself.